Daniel Khalaf

Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer

Matti Annala, Gillian Vandekerkhove, Daniel Khalaf et al. · Cancer Discovery · 2018 · 522 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

Daniel Khalaf, Matti Annala, Sinja Taavitsainen et al. · The Lancet Oncology · 2019 · 352 citations

Medicine, Oncology, Pharmacotherapy +17

Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer

Matti Annala, Werner J. Struss, Evan W. Warner et al. · European Urology · 2017 · 218 citations

Life Sciences, Genetics, Oncology +14

Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer

Gillian Vandekerkhove, Werner J. Struss, Matti Annala et al. · European Urology · 2019 · 183 citations

Medicine, Molecular Biology, Oncology +16

Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum

Lucia Nappi, Marisa Thi, Amy Lum et al. · Journal of Clinical Oncology · 2019 · 125 citations · Full text

Medicine, Cancer Biology, Oncology +17